1. aFarrell, N.InPlatinum-Based Drugs in Cancer Therapy;Kelland, L. R. and Farrell, N., Eds.Humana Press:Totowa, NJ, 2000; pp321–338.
2. bFarrell, N. and Spinelli, S.InUses of Inorganic Chemistry in Medicine;Farrell, N., Ed.Royal Society of Chemistry:Cambridge, U.K., 1999; pp124–134.
3. Farrell, N., Qu, Y., Bierbach, U., Valsecchi, M., and Menta, E.In30 Years of Cisplatin. Chemistry and Biochemistry of a Leading Anticancer Drug;Lippert, B., Ed.Verlag:Berlin, 1999; pp479–496.
4. Farrell, N.InPolynuclear Platinum Drugs. Metal Ions in Biological Systems;Sigel, A. and Sigel, H., Eds.Marcel Dekker, Inc.:New York, 2004; Vol.41, pp252–296.
5. Novel Approaches to Polynuclear Platinum Pro-Drugs. Selective Release of Cytotoxic Platinum−Spermidine Species through Hydrolytic Cleavage of Carbamates